DaVita's consensus analyst price target has been revised downward from $147.13 to $144.50. This change signals a modest adjustment in the market's outlook. The shift reflects an ongoing reassessment ...

We recently published 12 Fresh Stocks Jim Cramer Discussed Along With His Latest Thoughts On Quantum Computing . DaVita Inc. ...

Wondering if DaVita stock is trading at a bargain or an inflated premium? You are not alone, especially with so much chatter about where opportunities really lie in this market. Despite impressive ...

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an ...

DaVita (NYSE:DVA) is gearing up to announce its quarterly earnings on Monday, 2025-05-12. Here's a quick overview of what investors should know before the release. Analysts are estimating that DaVita ...

Let’s dig into the relative performance of DaVita (NYSE:DVA) and its peers as we unravel the now-completed Q3 outpatient & ...

DENVER (AP) — A jury on Friday acquitted Denver-based dialysis giant DaVita Inc. and former chairman and CEO Kent Thiry of charges that they conspired with three competing firms not to hire certain ...

A pharmacy services unit of the Denver-based dialysis provider DaVita Inc. will pay $63.7 million to resolve allegations it improperly billed federal health care programs and paid illegal financial ...

Discover why Fresenius Medical Care (FMS) is a buy - strong growth, dividend safety, and new product rollout promise ...

DaVita HealthCare Partners said Tuesday it will pay $389 million to settle criminal and civil anti-kickback investigations and plans to end joint ventures with kidney doctors involving 28 dialysis ...